Skye Bioscience Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 5AM VENTURE MANAGEMENT, LLC | 05/15/2026 | 9.68 M | $5.95 M | 0.00% | 24.41% |
| VERSANT VENTURE MANAGEMENT, LLC | 05/05/2026 | 2.01 M | $1.23 M | 0.00% | 5.06% |
| BAKER BROS. ADVISORS LP | 05/15/2026 | 1.58 M | $968.14 K | 8.59% | 3.97% |
| 05/15/2026 | 764.46 K | $470.14 K | 100.00% | 1.93% | |
| SPHERA FUNDS MANAGEMENT LTD. | 05/15/2026 | 678.93 K | $417.27 K | 41.76% | 1.71% |
| BLACKROCK, INC. | 05/13/2026 | 286.13 K | $175.86 K | 1.52% | 0.72% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 277.26 K | $170.45 K | 31.93% | 0.70% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 258.20 K | $158.69 K | -32.14% | 0.65% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 05/14/2026 | 233.10 K | $143.26 K | 0.00% | 0.59% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 104.23 K | $64.10 K | 100.00% | 0.26% |
| STATE STREET CORP | 05/15/2026 | 75.33 K | $46.30 K | 0.00% | 0.19% |
| CITADEL ADVISORS LLC | 05/15/2026 | 59.80 K | $36.75 K | 232.22% | 0.15% |
| UBS GROUP AG | 05/05/2026 | 45.76 K | $28.14 K | 244.44% | 0.12% |
| XTX TOPCO LTD | 05/15/2026 | 40.92 K | $25.15 K | -22.85% | 0.10% |
| CITADEL ADVISORS LLC | 05/15/2026 | 39.10 K | $24.03 K | -39.57% | 0.10% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 25.68 K | $15.79 K | -50.33% | 0.06% |
| ENGINEERS GATE MANAGER LP | 05/15/2026 | 20.19 K | $12.41 K | -12.72% | 0.05% |
| NORTHERN TRUST CORP | 05/14/2026 | 20.14 K | $12.38 K | 0.00% | 0.05% |
| BARCLAYS PLC | 05/15/2026 | 18.09 K | $11.12 K | -14.88% | 0.05% |
| GROUP ONE TRADING, L.P. | 05/13/2026 | 7.21 K | $4.43 K | -59.29% | 0.02% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 4.56 K | $2.80 K | 100.00% | 0.01% |
| MORGAN STANLEY | 05/15/2026 | 2.55 K | $1.57 K | -40.29% | 0.01% |
| FEDERATED HERMES, INC. | 05/11/2026 | 1.16 K | $712 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 600 | $364 | 29,900.00% | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 05/15/2026 | 400 | $242 | 0.00% | 0.00% |
| TD WATERHOUSE CANADA INC. | 05/12/2026 | 79 | $51 | 216.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/13/2026 | 66 | $39 | 0.00% | 0.00% |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 05/15/2026 | 52 | $32 | 0.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 05/14/2026 | 51 | $31 | 0.00% | 0.00% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 05/14/2026 | 39 | $24 | 0.00% | 0.00% |
| OPTIVER HOLDING B.V. | 06/02/2026 | 20 | $12 | 0.00% | 0.00% |
| CORECAP ADVISORS, LLC | 04/07/2026 | 8 | $5 | 0.00% | 0.00% |
| PLANTE MORAN FINANCIAL ADVISORS, LLC | 05/05/2026 | 3 | $2 | 0.00% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 2 | $1 | 100.00% | 0.00% |
| IFP ADVISORS, INC | 04/13/2026 | 2 | $1 | 100.00% | 0.00% |
| 05/14/2026 | 2 | $1 | 0.00% | 0.00% | |
| HARBOUR INVESTMENTS, INC. | 05/15/2026 | 1 | $1 | 0.00% | 0.00% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 05/05/2026 | 1 | $1 | -94.44% | 0.00% |
| LEO H. EVART, INC. | 05/14/2026 | 1 | $1 | 100.00% | 0.00% |
| PFS PARTNERS, LLC | 04/09/2026 | 1 | $1 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| CAPITAL ADVISORS INC/OK | 04/27/2026 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
| GSA CAPITAL PARTNERS LLP | 05/08/2026 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
Skye Bioscience Inc institutional Ownership - FAQ's
During the previous two years, 55 institutional investors and hedge funds held shares of Skye Bioscience Inc. The most heavily invested institutionals were:
5AM Venture Management, LLC: 9.68 M
Versant Venture Management, LLC: 2.01 M
BAKER BROS. ADVISORS LP: 1.58 M
SPHERA FUNDS MANAGEMENT LTD.: 678,928
BlackRock, Inc.: 286,131
GEODE CAPITAL MANAGEMENT, LLC: 277,256
40.67% of Skye Bioscience Inc stock is owned by institutional investors.
Institutional investors have bought a total of 18.11 M shares in the last 24 months. This purchase volume represents approximately $13.04 M in transactions.